Newsroom
Category
June 5, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly. Dharam Kaushik, MD, associate professor of urology, led the […]
June 5, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly. Dharam Kaushik, MD, associate professor of urology, led the […]
June 4, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers also showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly.
June 3, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, was interviewed about the new study in The Lancet featuring data from the COVID-19 and Cancer Consortium. Mesa said the results from the nearly 1,000 patients showed the death rate of cancer patients who contract COVID-19 is about 13%, twice the rate of the general population. […]
June 2, 2020
This is the first abstract submitted by the Mays Cancer Center to be selected for presentation at the AACI meeting.
June 1, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, is featured in this story about the results of a new COVID-19 and Cancer Consortium study published in The Lancet. According to the study, cancer patients who get COVID-19 have a 13% risk of dying, more than double the rate for all patients with COVID-19 combined. […]